Skip to main content

marstacimab

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal ID6342: Marstacimab for treating severe haemophilia A or severe haemophilia B in people 12 years and over

Medicine details

Medicine name marstacimab
Formulation solution for infusion
Reference number 4883
Indication

Treatment of severe haemophilia A or severe haemophilia B in people 12 years and over

Company Pfizer Ltd
BNF chapter Nutrition & blood
Submission type N/A
Status Excluded due to NICE appraisal
Date of issue 12/12/2024
NICE guidance

ID6342: Marstacimab for treating severe haemophilia A or severe haemophilia B in people 12 years and over

Follow AWTTC: